1Scandinavian Simvastatin Survival Group.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the scandinavian simvastin survival study (4S).Lancet,1994,344:1383-1389.
2Shepherd J,Cobbe SM,Ford I,et al.For the West of Scotland Coronary Prevention Study Group.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia.N Engl J Med,1995,333:1301-1307.
3Enomoto N,Takase S,Yasuhara M,et al.Acetaldehyde metabolism in different aldehyde ehydrogenase-2 genotypes.Alcohol Clin Exp Res,1991,15:141-144.
4Tybjaerg-Hansen A,Steffenson R,Meinertz H,et al.Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.N Engl J Med,1998,338:1577-1584.
5Georgia S,Simon S,Julian PTH.Obstacles and opportunities in meta-analysis of genetic association studies.Genetics In Medicine,2005,7:13-20.
6Martijn BK.Commentary:Mendelian randomization,18 years on.Int J Epidemiol,2004,33:10-11.
7Martin DT,Cosetta M,Paul RB,et al.Commentary:Development of Mendelian randomization:from hypothesis test to "Mendelian deconfounding".Int J Epidemiol,2004,33:26-29.
8George DS,Shah E.Mendelian randomization:can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol,2003,32:1-22.
9Cosetta M,John RT,Martin DT,et al.An integrated approach to the Meta-analysis of genetic association studies using Mendelian randomization.Am J Epidemiol,2004,160:445-452.
10Duncan CT,David VC.Commentary:The concept of "Mendelian randomization".Int J Epidemiol,2004,33:21-25.
